Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Howell

Showing results (31-40 of 260) with videos related to

Pageof 26
Sort By:
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|February 1, 1990
Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistanceP A Andrews, S B Howell
The American Journal of Medicine|February 1, 1976
Circulating immunoglobulin complexes in Wegener's granulomatosisS B Howell, W V Epstein
Gynecologic Oncology|January 1, 1990
A review: intraperitoneal cisplatin in the management of patients with ovarian cancerE F McClay, S B Howell
European Journal of Cancer & Clinical Oncology|July 1, 1983
Modulation of plasma cyst(e)ine by cisplatinW E Wung, S B Howell
Clinical Chemistry|November 1, 1980
Simultaneous liquid chromatography of 5-fluorouracil, uridine, hypoxanthine, xanthine, uric acid, allopurinol, and oxipurinol in plasmaW E Wung, S B Howell
Biochemical Pharmacology|September 15, 1981
Differential toxicity of carrier-bound methotrexate toward human lymphocytes, marrow and tumor cellsB C Chu, S B Howell
The Journal of Biological Chemistry|August 23, 1996
Paclitaxel activation of the GADD153 promoter through a cellular injury response element containing an essential Sp1 binding siteD P Gately, S B Howell
Cancer Research|August 1, 1985
Mechanism of synergy between N-phosphonacetyl-L-aspartate and dipyridamole in a human ovarian carcinoma cell lineT C Chan, S B Howell
Cancer Treatment Reports|June 1, 1985
Pharmacokinetics of hexamethylmelamine administered via the Ip route in an oil emulsion vehicleA D Wickes, S B Howell
European Journal of Cancer & Clinical Oncology|April 1, 1989
Unexpected synergy between N-phosphonacetyl-L-aspartate and cytidine against human tumor cellsT C Chan, S B Howell
Pageof 26

Showing results (31-40 of 260) with videos related to

Sort By:
Pageof 26
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|February 1, 1990
Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistanceP A Andrews, S B Howell
The American Journal of Medicine|February 1, 1976
Circulating immunoglobulin complexes in Wegener's granulomatosisS B Howell, W V Epstein
Gynecologic Oncology|January 1, 1990
A review: intraperitoneal cisplatin in the management of patients with ovarian cancerE F McClay, S B Howell
European Journal of Cancer & Clinical Oncology|July 1, 1983
Modulation of plasma cyst(e)ine by cisplatinW E Wung, S B Howell
Clinical Chemistry|November 1, 1980
Simultaneous liquid chromatography of 5-fluorouracil, uridine, hypoxanthine, xanthine, uric acid, allopurinol, and oxipurinol in plasmaW E Wung, S B Howell
Biochemical Pharmacology|September 15, 1981
Differential toxicity of carrier-bound methotrexate toward human lymphocytes, marrow and tumor cellsB C Chu, S B Howell
The Journal of Biological Chemistry|August 23, 1996
Paclitaxel activation of the GADD153 promoter through a cellular injury response element containing an essential Sp1 binding siteD P Gately, S B Howell
Cancer Research|August 1, 1985
Mechanism of synergy between N-phosphonacetyl-L-aspartate and dipyridamole in a human ovarian carcinoma cell lineT C Chan, S B Howell
Cancer Treatment Reports|June 1, 1985
Pharmacokinetics of hexamethylmelamine administered via the Ip route in an oil emulsion vehicleA D Wickes, S B Howell
European Journal of Cancer & Clinical Oncology|April 1, 1989
Unexpected synergy between N-phosphonacetyl-L-aspartate and cytidine against human tumor cellsT C Chan, S B Howell
Pageof 26